NCT01231347 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT01226901 A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) Status TERMINATED Phase PHASE1
NCT01222546 Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01214668 Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01212341 Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor Status COMPLETED Phase PHASE1
NCT01199224 To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01197885 Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT01197170 Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance Status COMPLETED Phase PHASE1
NCT01190644 Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors Status TERMINATED Phase PHASE2
NCT01170975 Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules Status COMPLETED Phase PHASE1
NCT01168752 Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma Status COMPLETED Phase PHASE1
NCT01166035 Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT01165385 Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01159522 A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy Status COMPLETED Phase PHASE1
NCT01158079 Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment Status COMPLETED Phase PHASE1
NCT01151384 Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors Status COMPLETED Phase PHASE1